Výsledky vyhledávání - "Keizo Kajiwara"

Akademický článek

Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels

Autor: Kunio Hieshima, Seigo Sugiyama, Akira Yoshida, Noboru Kurinami, Tomoko Suzuki, Hiroko Ijima, Fumio Miyamoto, Keizo Kajiwara, Katsunori Jinnouchi, Tomio Jinnouchi, Hideaki Jinnouchi

Publikováno v: Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 617-625 (2020)

Abstract Aims/Introduction The renal threshold for glucose (RTg) corresponds to a blood glucose level of ~180 mg/dL; however, in hospitals, patients are often encountered who are hyperglycemic, but urine glucose test strip‐negative, who remain nega

Externí odkaz: https://doaj.org/article/ea9220535e6942029004990f72a09126

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus

Autor: Hideaki Jinnouchi, Seigo Sugiyama, Akira Yoshida, Kunio Hieshima, Noboru Kurinami, Tomoko Suzuki, Fumio Miyamoto, Keizo Kajiwara, Kunihiko Matsui, Tomio Jinnouchi

Publikováno v: Journal of Diabetes Research, Vol 2015 (2015)

Aims. Glucagon-like peptide-1 (GLP-1) analog promotes insulin secretion by acting on pancreatic β-cells. This antihyperglycemic treatment for type 2 diabetes mellitus (DM) has attracted increased clinical attention not only for its antihyperglycemic

Externí odkaz: https://doaj.org/article/997933f938f24c579d57859cb800a18d

Zobrazit plný text záznamu

Elevation of the renal threshold for glucose is associated with insulin resistance and higher glycated hemoglobin levels

Autor: Fumio Miyamoto, Katsunori Jinnouchi, Tomoko Suzuki, Noboru Kurinami, Hideaki Jinnouchi, Hiroko Ijima, Tomio Jinnouchi, Keizo Kajiwara, Kunio Hieshima, Seigo Sugiyama, Akira Yoshida

Publikováno v: Journal of Diabetes Investigation
Journal of Diabetes Investigation, Vol 11, Iss 3, Pp 617-625 (2020)

Aims/Introduction The renal threshold for glucose (RTg) corresponds to a blood glucose level of ~180 mg/dL; however, in hospitals, patients are often encountered who are hyperglycemic, but urine glucose test strip‐negative, who remain negative for

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3cf8e781781766de9d4e051908fcda
https://doi.org/10.1111/jdi.13191

Zobrazit plný text záznamu

Plný text ve formátu HTML

Initial Acute Decline in Estimated Glomerular Filtration Rate After Sodium-Glucose Cotransporter-2 Inhibitor in Patients With Chronic Kidney Disease

Autor: Seigo Sugiyama, Akira Yoshida, Katsunori Jinnouchi, Tomio Jinnouchi, Keizo Kajiwara, Tomoko Suzuki, Noboru Kurinami, Motoko Tanaka, Fumio Miyamoto, Kunio Hieshima, Hideaki Jinnouchi

Publikováno v: Journal of Clinical Medicine Research

Background: Renal function deterioration accompanied by an acute decrease in estimated glomerular filtration rate (eGFR) was observed early after starting sodium-glucose cotransporter-2 inhibitor (SGLT2i) therapy. It is unclear how much and how frequ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3bfa5a471e47ee66f2e7316bbc4e31c
https://doi.org/10.14740/jocmr4351

Zobrazit plný text záznamu

Renoprotective Effects of Additional SGLT2 inhibitor Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3b-4: A Real World Report From A Japanese Specialized Diabetes Care Center

Autor: Noboru Kurinami, Seigo Sugiyama, Tomio Jinnouchi, Katsunori Jinnouchi, Akira Yoshida, Kunio Hieshima, Fumio Miyamoto, Tomoko Suzuki, Motoko Tanaka, Hideaki Jinnouchi, Keizo Kajiwara

Publikováno v: Journal of Clinical Medicine Research

Background: Large randomized clinical trials of patients with type 2 diabetes mellitus (T2DM) and at high risk for cardiovascular disease revealed that sodium-glucose cotransporter 2 (SGLT2) inhibitors significantly reduced renal events. However, the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9548e6321e490ea0895c4c62e150d14
https://doi.org/10.14740/jocmr3761

Zobrazit plný text záznamu

Changes in urinary glucose concentration and body weight in patients treated with the selective SGLT2 inhibitor luseogliflozin

Autor: Keizo Kajiwara, Seigo Sugiyama, Kunio Hieshima, Katsunori Jinnouchi, Hiromi Tsuyuno, Akira Yoshida, Tomio Jinnouchi, Hideaki Jinnouchi, Noboru Kurinami, Tomoko Suzuki, Kiyoko Iwamoto

Publikováno v: Diabetes research and clinical practice. 182

We investigated the effects of the SGLT2 inhibitor luseogliflozin on blood and urinary glucose and body weight.Luseogliflozin 2.5 mg was administered once daily for 24 weeks to 30 outpatients with type 2 diabetes. Urinary glucose concentration, conti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eada9f55ea806b15215586645bbecb9a
https://pubmed.ncbi.nlm.nih.gov/34119556

Zobrazit plný text záznamu

Body Muscle-to-Fat Ratio, Rather Than Fat-to-Muscle Ratio, Significantly Correlates With Measured Insulin Resistance in Patients With Type 2 Diabetes Mellitus

Autor: Noboru Kurinami, Akira Yoshida, Seigo Sugiyama, Keizo Kajiwara, Tomio Jinnouchi, Fumio Miyamoto, Katsunori Jinnouch, Masatoshi Nomura, Kunio Hieshima, Hideaki Jinnouchi

Publikováno v: Journal of Clinical Medicine Research

Background: Insulin resistance (IR) assessment is important in treating type 2 diabetes mellitus (T2DM). We thus compared body muscle-to-fat ratio (BMFR) and fat-to-muscle ratio (FMR) values against M/I values as clinical index of IR. Methods: Subjec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::702bc8059ce09b86cc14f8a091c9e91d
https://pubmed.ncbi.nlm.nih.gov/34394781

Zobrazit plný text záznamu

Dapagliflozin significantly reduced liver fat accumulation associated with a decrease in abdominal subcutaneous fat in patients with inadequately controlled type 2 diabetes mellitus

Autor: Keizo Kajiwara, Akira Yoshida, Hideaki Jinnouchi, Kunio Hieshima, Noboru Kurinami, Tomio Jinnouchi, Seigo Sugiyama, Fumio Miyamoto, Katsunori Jinnouch

Publikováno v: Diabetes Research and Clinical Practice. 142:254-263

Aims We examined dapagliflozin-induced changes in liver fat accumulation. Methods We prospectively recruited Japanese patients with inadequately controlled type 2 diabetes mellitus (T2DM) [hemoglobin A1c (HbA1c) >7.0%]. Dapagliflozin (5 mg/day) or no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52c32bf7d6e79f3fceee6af014497cb8
https://doi.org/10.1016/j.diabres.2018.05.017

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání